Why it was recalled
CGMP Deviations: products were stored outside the drug label specifications.
Product description
A&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDC 11523-0096-3.
Lot numbers, UPCs & expiration codes
No codes were listed in the FDA report.
Where it was sold
Nationwide in the USA.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1322-2022
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jun 29, 2022
- FDA report date
- Aug 17, 2022
- Quantity
- 1 Jar
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office
Original FDA data
Every field from FDA enforcement report D-1322-2022, exactly as published.
Show all FDA fields
- City
- Richmond
- State
- VA
- Status
- Terminated
- Country
- United States
- Event ID
- 90553
- Address
- 9954 Maryland Drive
- Address (line 2)
- Deep Run Iii Ste. 4000
- Postal code
- 23233
- Report date
- Aug 17, 2022
- Product type
- Drugs
- Recall number
- D-1322-2022
- Classification
- Class II
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Product quantity
- 1 Jar
- Termination date
- Feb 13, 2024
- Reason for recall
- CGMP Deviations: products were stored outside the drug label specifications.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- A&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDC 11523-0096-3.
- Distribution pattern
- Nationwide in the USA.
- Recall initiation date
- Jun 29, 2022
- Initial firm notification
- Letter
- Center classification date
- Aug 5, 2022